New Heart Studies with Focus on Prevention and Early Diagnosis

Filed in archive Arthritis , Cancer , Cardiovascular Health , Medical Devices on May 13, 2009

The new studies that will be released by Medtronic this week could help improve cancer and arthritis diagnosis in heart patients.

The groundbreaking research includes data on the world's first pacemaker designed for use in an MRI machine, giving pacemaker patients access to one of the leading diagnostic tools for many diseases, such as cancer and arthritis. The research is late-breaking data from a major randomized clinical trial on the investigational EnRhythm MRI SureScan Pacing System and will be released today, May 14.

"The breadth and depth of our presence at Heart Rhythm 2009 underscores the ongoing innovation behind Medtronic's Cardiac Rhythm Disease Management portfolio and our continued leadership in meeting unmet medical needs to improve the lives of patients," said Pat Mackin, president of the Cardiac Rhythm Disease Management business and senior vice president at Medtronic. "Our scientists and engineers continue to transform cardiac disease through innovative therapies and market-leading disease management, diagnostics and monitoring solutions."

More than 80 studies will be released by Medtronic at the Heart Rhythm Society Convention in Boston this week. The release highlighting all announcements can be found here.